GANGLOFF SCOTT A. (Chief Technology Officer) reported 2 transactions at AKERO THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/9/2025ACC: 0001193125-25-312111
Officer· Chief Technology Officer
Since Apr 2024
-322.45K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
322.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.09K
Price / share
—
Trade value
—
% of position
New position
12/9/2025
5.09K→0.00
Common Stock
Direct
Shares
−21.26K
Price / share
—
Trade value
—
% of position
New position
12/9/2025
21.26K→0.00
Total
Net shares
−26.35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | D · Disposition | −5.09K | — | — | New position | 5.09K | 0.00 |
| Common Stock Direct | 12/9/2025 | D · Disposition | −21.26K | — | — | New position | 21.26K | 0.00 |
| Total | −26.35K | $0.00 | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
17.78K shares
Shares
−17.78K
Strike price
19.62
Held after
0.00
Exercisable
—
12/9/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
73.70K shares
Shares
−73.70K
Strike price
29.23
Held after
0.00
Exercisable
—
12/9/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
204.62K shares
Shares
−204.62K
Strike price
19.62
Held after
0.00
Exercisable
—
12/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.78K shares | 12/9/2025 | D · Disposition | −17.78K | 19.62 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock73.70K shares | 12/9/2025 | D · Disposition | −73.70K | 29.23 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock204.62K shares | 12/9/2025 | D · Disposition | −204.62K | 19.62 | — | 0.00 |